SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-070778
Filing Date
2019-12-09
Accepted
2019-12-09 07:00:42
Documents
16
Period of Report
2019-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924746d1_8k.htm   iXBRL 8-K 53513
2 EXHIBIT 4.1 tm1924746d1_ex4-1.htm EX-4.1 132479
3 EXHIBIT 4.2 tm1924746d1_ex4-2.htm EX-4.2 48079
4 EXHIBIT 99.1 tm1924746d1_ex99-1.htm EX-99.1 10045
5 GRAPHIC image_001.jpg GRAPHIC 21256
  Complete submission text file 0001104659-19-070778.txt   491027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20191206.xsd EX-101.SCH 3222
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20191206_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20191206_pre.xml EX-101.PRE 22734
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1924746d1_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 191274307
SIC: 2836 Biological Products, (No Diagnostic Substances)